435 related articles for article (PubMed ID: 30382619)
21. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
22. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
23. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
Lin GB; Zhang CM; Chen XY; Wang JW; Chen S; Tang SY; Yu TQ
Math Biosci Eng; 2019 Nov; 17(1):834-844. PubMed ID: 31731380
[TBL] [Abstract][Full Text] [Related]
24. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
25. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
26. Novel combination of serum microRNA for detecting breast cancer in the early stage.
Shimomura A; Shiino S; Kawauchi J; Takizawa S; Sakamoto H; Matsuzaki J; Ono M; Takeshita F; Niida S; Shimizu C; Fujiwara Y; Kinoshita T; Tamura K; Ochiya T
Cancer Sci; 2016 Mar; 107(3):326-34. PubMed ID: 26749252
[TBL] [Abstract][Full Text] [Related]
27. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
28. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y
J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969
[TBL] [Abstract][Full Text] [Related]
29. The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?
Kaba M; Pirinççi N; Demir M; Kaba S; Oztuzcu S; Verep S
Int Urol Nephrol; 2023 Oct; 55(10):2483-2491. PubMed ID: 37338656
[TBL] [Abstract][Full Text] [Related]
30. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
31. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
32. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
[TBL] [Abstract][Full Text] [Related]
33. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
[TBL] [Abstract][Full Text] [Related]
34. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
Scheffer AR; Holdenrieder S; Kristiansen G; von Ruecker A; Müller SC; Ellinger J
World J Urol; 2014 Apr; 32(2):353-8. PubMed ID: 23266581
[TBL] [Abstract][Full Text] [Related]
35. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
[TBL] [Abstract][Full Text] [Related]
36. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
37. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients.
Duran-Sanchon S; Vila-Navarro E; Marcuello M; Lozano JJ; Muñoz J; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; Herreros-Villanueva M; Martín AC; Pérez-Palacios R; Arroyo R; Castells A; Gironella M
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877644
[TBL] [Abstract][Full Text] [Related]
38. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
[TBL] [Abstract][Full Text] [Related]
39. Expression profile of microRNAs (106b-3p, 130b-3, 145-3p, 199a-5p) in urine and serum samples from patients with the diagnosis of bladder cancer.
Kutwin P; Borkowska EM; Bogucka P; Jabłonowski Z
Pol Merkur Lekarski; 2021 Apr; 49(290):103-107. PubMed ID: 33895754
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]